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Abstract 
 
Background: The core symptoms of bulimia nervosa (BN) and binge eating disorder (BED) are 
recurrent episodes of binge eating. Despite negative psychological and physical consequences, 
BN/BED patients show uncontrollable approach tendencies towards food. This cognitive bias occurs 
at an early stage of information processing. Cognitive bias modification (CBM) directly targets such 
biases and has been shown to be effective in treating several mental disorders. In alcohol addiction, 
automatic action tendencies towards alcohol cues and relapse rates were successfully reduced by a 
specific form of CBM, termed approach bias modification. Based on these findings and data from a 
proof-of-concept study in people with high levels of food craving, CBM is considered a promising 
new treatment approach for BN/BED. Given the similarities between BN/BED and addictive 
disorders, the rationale for using approach bias modification appears to be particularly strong. The 
aim of the present study is to examine whether, compared to a sham training, computerised 
approach bias modification (10 sessions) can reduce binge eating episodes in BN/BED patients from 
pre-treatment to follow-up. Additionally, we will investigate whether this CBM programme also 
reduces global eating disorder psychopathology, trait and cue-elicited food craving, food intake as 
well as approach and attentional bias towards visual food cues. Treatment acceptance will be 
determined by attrition rates and responses on a feedback-form. 
 
Methods: This is a randomised, double-blind, placebo-controlled superiority trial with two parallel 
arms. A total of 54 BN/BED patients will be recruited. Approach bias towards food will be retrained 
by a computer task adopting an implicit learning paradigm. Patients in the control condition (sham) 
will conduct a similar task but will not be trained to avoid food cues. Methods against bias include 
public registration, randomisation by a central study office, standardisation of the treatments, and 
blinding of assessors. Furthermore, the session number and duration will be equivalent in the two 
conditions.  
 
Discussion: This is the first registered randomised-controlled trial of approach bias modification in a 
clinical BN/BED sample. Results from this study will provide an indication of the efficacy of approach 
bias modification training for BN/BED and the potential mechanisms of action underlying this 
treatment. 
 
Trial registration: DRKS00010231 (retrospectively registered on 24/03/2016; first version) 
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Background 
   
Bulimia nervosa (BN) and Binge Eating Disorder (BED) are common and serious mental disorders 
with elevated all-cause mortality, comorbidity, and high relapse rates [1-4]. They share repeated 
episodes of binge eating as key characteristics [5]. Several authors have highlighted the addiction-
like features in BN and BED [6-9] such as uncontrollable approach tendencies towards binge food 
despite significant negative psychological and physical consequences.  
 According to dual-process models, two distinct systems of information processing contribute to 
the evaluation of food cues and the control of eating behaviour, i.e. an impulsive system that 
operates rapidly and automatically (i.e. mostly outside of conscious control), and a reflective system 
that operates slower and more deliberately [10, 11]. The impulsive system evaluates food cues 
primarily regarding their current emotional and motivational significance. In contrast, the reflective 
system involves higher-order processes of cognitive control, deliberate decisions, and impulse 
regulation that take long-term consequences into account. It is thought that in addictive disorders, 
the impulsive system dominates to a large degree the initiation of addictive behaviour, whereas the 
reflective system lacks power to control this behaviour [11]. Supporting this assumption, bulimic 
eating disorders such as BN and BED are associated with strong, impulsive responses and poor 
cognitive control towards food cues, which is considered to contribute to a heightened susceptibility 
to sensitized cues that trigger action tendencies and lead to binge eating [12]. Hence, even though 
people with a bulimic eating disorder may be aware of the negative consequences of binge eating, 
they may still engage in it when food cues are processed in the impulsive system. This is reflected by 
findings that individuals with bulimic eating disorders show appetitive physical responses towards 
food cues despite rating them as anxiety-provoking and disgusting [13, 14]. A rapidly growing body 
of research shows that eating disorders and unhealthy eating behaviour are associated with 
cognitive biases that unfold their negative effects in the impulsive system during the automatic 
processing of food cues, particularly by increasing attention and approach tendencies towards food 
[14-21]. 
 Traditional (talking) psychotherapy programmes may not be best suited to directly modulate such 
biases that occur at an early stage in information processing and that often operate outside of 
conscious control [11, 22, 23]. In an effort to create more suitable interventions, researchers have 
translated findings from basic research and developed cognitive bias modification (CBM) 
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programmes that are considered to provide a way to more directly target such biases. Different CBM 
programmes have been shown to be effective in treating mental disorders such as depression [24], 
social phobia [25], and addictive disorders [26-29]. With regards to the latter, several studies have 
used an approach bias modification training in alcohol-dependent participants and found this to 
effectively reduce automatic action tendencies towards alcohol cues and relapse rates [27, 29, 30]. 
Several meta-analyses have demonstrated the efficacy of CBM across different mental disorders [31-
35]. Consequently, CBM has also been suggested as a potential new treatment approach for eating 
disorders [22, 23]. Recently, it was shown that approach bias modification reduces approach bias 
towards food cues and actual food intake in female student populations [36, 37]. However, it is yet 
unknown whether such a training is equally effective in clinical samples of patients with BN/BED. In 
addition, the efficacy may also depend on the use of multiple sessions of training [38].  
 In a proof-of-concept study [39] we recently evaluated the efficacy of such an approach bias 
modification training in a sample of people with high levels of food craving and subthreshold bulimic 
symptoms. Both the targeted approach bias towards food cues and also attentional bias towards 
food, trait and cue-elicited food craving as well as more general eating disorder symptoms were 
significantly reduced during the training with medium to large effect sizes in this study. The initial 
approach bias towards visual food cues was not only reduced (as hypothesised) but actually turned 
into an avoidance bias. Furthermore, all participants completed the intervention and the majority of 
them perceived the training as effective in altering daily eating habits. Taken together, these highly 
promising findings suggested that retraining automatic action tendencies in people with bulimic 
symptoms by means of computerised CBM may be an effective, feasible and acceptable way of 
reducing cognitive biases, food craving and binge eating. Thus, a randomised controlled trial with BN 
and BED patients appeared to be the logical next step.  
 According to the emotional distress hypothesis of binge eating, cognitive biases constitute  latent 
vulnerability factors that become evident when the individual is confronted with a stressor [40]. 
Consequently, CBM should be most effective in its impact on cognitive biases and subsequent eating 
behaviour upon exposure to stressful situations. In fact, it has been demonstrated that CBM 
attenuates the effects of stressors on symptoms of depression and anxiety [41, 42]. Furthermore, 
there is a common theoretical basis and strong empirical evidence that negative affect (in response 
to a stressor) is a key trigger of attentional bias towards food and of binge eating [43-46]. Therefore, 
we applied a vulnerability-stress model for our CBM programme by using stimuli that induce 
moderate levels of negative affect before cognitive bias training and assessment.  
 
Aims 
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The central aim of this randomised controlled pilot trial is to examine whether a specifically tailored 
brief (10 sessions), computerised CBM training (approach bias modification vs. sham) is able to 
reduce binge eating episodes in BN and BED patients (primary efficacy endpoint). More precisely, 
from pre-treatment to 2-months follow-up, BN and BED patients who receive real CBM are expected 
to report a greater reduction in the number of objective binge eating episodes during the previous 2 
months than those who received sham CBM. 
 Additionally, we will investigate whether this CBM programme reduces global eating disorder 
psychopathology from pre-treatment to follow-up, and trait and cue-elicited food craving, food 
intake, and approach and attentional bias towards visual food stimuli in BN and BED patients from 
pre- to post-treatment. Finally, we will assess treatment acceptance by attrition rates and by means 
of a specifically designed feedback form. Specifically, as compared to patients in the sham CBM 
condition, patients in the real CBM condition are expected to show (a) decreased global eating 
disorder psychopathology from pre-treatment to follow-up, and (b) decreased approach and 
attentional bias towards food cues, (c) decreased state food craving after cue exposure, (d) 
decreased trait food craving as well as (e) reduced food intake in a bogus taste test from pre- to 
post-treatment. In an exploratory analysis we will examine the patients’ acceptance of this specific 
CBM intervention, taking dropout rates and scores on a feedback form into account (treatment 
acceptance). 
 
Methods 
Design 
This is a superiority trial adopting a double-blind, randomised placebo-controlled parallel-group 
design comparing real and sham CBM. Participants with BN or BED will be randomly allocated to 
receive either 10 sessions (15 mins each) of real CBM (treatment group) or sham CBM (control 
group) in a period of 4 weeks. Participants will be recruited from two different sites (Heidelberg, 
Germany and London, UK). Outcomes will be assessed at baseline, post-treatment, and 2-months 
follow-up. The study protocol is outlined in Figure 1, and Table 1 provides details of all assessments 
at the different time points. 
 
Ethical Approval and Trial Registration 
Ethical approval for the ABBA trial was obtained from the Ethics Committee of the Medical Faculty at 
Heidelberg University, Germany (S-100/2014) and from the London - Riverside Research Ethics 
Committee, UK (REC ref: 16/LO/0018). The study is registered on the German Clinical Trials Register 
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(DRKS; registration number: DRKS00010231) which is an approved Primary Register in the WHO 
network and thus meets the requirements of the ICMJE. 
 
Participants and recruitment 
Participants will be recruited from the outpatient units of the Department of General Internal 
Medicine and Psychosomatics at University Hospital Heidelberg, the South London and Maudsley 
NHS Foundation Trust’s Specialist Adult Eating Disorders Unit, and through websites, circular mails, 
advertising posters, and adverts in local media. 
 
Inclusion criteria 
Women and men will be eligible for participation if they are aged 18 years or above and meet the 
criteria of a DSM-5 diagnosis of BN or BED [5].  
 
Exclusion criteria 
Exclusion criteria are: (a) age under 18 years; (b) medical (e.g. electrolyte abnormalities) or 
psychiatric (e.g. acute suicidality) instability; (b) need for immediate inpatient treatment; (c) lifetime 
diagnosis of substance dependence, psychosis, bipolar disorder, ADHD, or borderline personality 
disorder; (d) psychotropic medication other than selective serotonin reuptake inhibitors (patients 
have to be on a stable medication, i.e. at least 14 days of SRRI during participation in the trial); (e) 
severe learning disability that affects patients’ ability to complete study assessments/treatment; (f) 
inability to speak fluent English/German (depending on study site), impacting on patients ability to 
complete study assessments/treatment. 
 
Sample size 
Previous randomised controlled trials comparing real and sham versions of approach bias 
modification in clinical samples applied a repeated measures ANOVA design (group x time) to 
examine treatment-specific changes and have reported small-to-medium effect sizes (ηp2 between 
0.05 and 0.06) [27, 47, 48]. Using the smallest effect size that has previously been reported, a total 
sample size of 40 patients will have 80% power to detect an effect of this size using a 2 x 2 repeated 
measures ANOVA with a 0.05 two-tailed significance level. The percentage of data lost owing to 
errors in the applied neuropsychological tasks was 7% at the maximum in previous studies. Taking 
this and a potential dropout rate of 25% into account, a minimum of 53 patients must be included. 
Thus, we will recruit 27 patients for each group (total n = 54). 
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Intervention 
Patients in the real CBM condition will conduct a treatment version of the Food Approach-Avoidance 
Task (Food-AAT) [39]. In this task, participants are shown colour photographs of food and control 
(i.e. neutral household and office) items on a computer screen. They are required to pull or push a 
joystick in response to the outline of the picture (round vs. rectangular), irrespective of picture 
content. Format movement assignments are counterbalanced among participants (i.e. half will push 
round pictures and half will push rectangular pictures). When the joystick is pulled, the picture grows 
bigger and when it is pushed it grows smaller. This zooming-in and zooming-out emphasizes 
respective sensations of approaching and avoiding and thus combines the proprioceptive (arm 
movement) and exteroceptive (zooming feature) cues of approach and avoidance behaviour [49]. 
The treatment version of the Food-AAT adopts an implicit learning paradigm by presenting all food 
pictures in the “push” (i.e. avoid) format so that participants learn to link avoidance movement to 
visual cues of high calorie food. Patients will receive ten 15 minutes sessions of training over a 4 
weeks period.  
 Patients in the control condition (sham CBM) will receive the same dosage of the same task but 
will not be trained to avoid food cues in the Food-AAT. Instead, patients in the control condition 
receive 10 additional sessions of the pre-and post-treatment assessment version of the task (Food-
AAT), which requires an equal number of approach and avoidance movements to both food and 
non-food pictures. Sham (placebo) CBM with an equal dosage, frequency, and character was chosen 
as the comparator treatment in order to examine the specific effects of this form of CBM. 
 Sessions will take place in dedicated research facilities. In line with the vulnerability-stress model 
of cognitive biases described in the introduction [50], participants will be presented with a set of 
pictures that are considered to induce mild levels of negative mood at the beginning of every 
training session (60 images; duration: approx. 1 min.) [51].  
  Study adherence: A researcher will be present throughout the training and assessment sessions 
to ensure study adherence. The interventions are pre-defined, computerised tasks. Any deviation 
from the study protocol will be recognised and recorded immediately. We will ask participants to 
refrain from any other treatment focusing on their eating disorder. However, if clinical need dictates 
another treatment, this will be documented but will not lead to the exclusion of the participant. 
Participants are allowed to discontinue the treatment at any time. 
 
Procedure 
A flowchart outlining the study procedures is presented in Figure 1. For further information about 
the time schedule of enrolment, interventions and study assessments, please see Table 1. 
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(Insert Figure 1 and Table 1 here) 
 
Screening 
Potential participants will be referred to the study by their clinician or by themselves. Study 
researchers will screen participants for eligibility. Screening includes the Structured Clinical Interview 
for DSM Disorders (SCID) [52-54], a short inclusion/exclusion screen specific to this study, and an 
assessment of medical and psychiatric history, and medication dosage and stability. Once eligibility 
has been confirmed, the patient’s written informed consent will be obtained by the researchers. In 
line with the CONSORT guidelines, we will record the number and reasons for any participants we 
must exclude, or any who decline consent or withdraw from the study. 
 
Baseline assessment 
Binge-eating frequency and general eating disorder symptomatology will be assessed in terms of a 
specific, structured clinical interview, i.e. the Eating Disorders Examination [55, 56]. Participants will 
also be weighed and asked to complete a battery of questionnaires relating to eating disorder 
symptomatology, food craving, depression and anxiety, as well as neuropsychological computer 
tasks that assess approach bias and attentional bias towards visual food cues and working memory. 
Furthermore, state levels of food craving after cue exposure and food intake will be assessed in 
laboratory tasks. 
 Once the baseline assessment is completed, participants will be randomly allocated to the 
treatment (real CBM) or control (sham CBM) group. Randomisation will be performed independently 
from the trial team by a central study office at Heidelberg University Hospital. The first CBM session 
will start on the day of the baseline assessment. Participants in the sham group will be offered the 
opportunity to receive real CBM after the end of follow-up.  
 
Post-treatment assessment: 
The post-treatment assessment will take place after the last training session, and will include the 
same elements as the baseline assessment except for the Eating Disorders Examination. 
 
Two months follow-up: 
Two months after the post-treatment assessment a follow-up session will be conducted which will 
involve the Eating Disorders Examination. Finally, blinding success will be evaluated by asking 
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participants to guess the treatment allocation. Participants will be un-masked and individuals in the 
control group will then be offered the real treatment.  
 
Measures 
 
Screening measures 
 Body Mass Index (kg/m2) 
 Screening module of the SCID [52-54]: This semi-structured psychiatric interview will be used 
as a diagnostic screen to assess the presence of psychiatric comorbidities. 
 The depression module of the Patient Health Questionnaire (PHQ-9) [57, 58] and the 
General Anxiety Disorder Screener-7 (GAD-7) [59, 60] are reliable and valid as well as widely 
used self-report instruments to assess symptoms of depression and anxiety according to the 
DSM. 
 
Primary outcome measure 
 Eating Disorder Examination (EDE) [55, 56]: The primary outcome variable in this study is the 
treatment-specific change from baseline to 2-months follow-up in the number of objective 
binge eating episodes as assessed by the EDE. The EDE is a reliable and valid as well as 
widely used measure of eating disorder symptoms and is regarded as the instrument of 
choice for the assessment and diagnosis of eating disorders according to the Diagnostic and 
Statistical Manual of Mental Disorders. 
 
Secondary outcome measures 
 Food Approach-Avoidance Task, assessment version [16, 39, 61]: this task will be used to assess 
approach bias towards visual cues of high calorie food (expected target cognitive mechanism of 
intervention). It is identical to the treatment version except that in the assessment version of the 
task, the required response is unrelated to the picture content (i.e. food and neutral stimuli are 
presented equally often in round and rectangular, i.e. push and pull, format). The approach bias 
towards food is calculated by subtracting the median reaction time (RT) for pulling food pictures 
from the median RT for pushing pictures of this category [61]. Thus, a positive value denotes an 
approach bias (i.e. the participant is faster in pulling than in pushing food pictures), whereas a 
negative value indicates an avoidance bias.  
 Visual probe task [62]: This task will be used to assess participants’ attentional bias towards 
visual food cues. During this computer task picture pairs (food/non-food) are presented side by 
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side on a computer screen after the presentation of a fixation point at the centre of the screen  
and are followed by the presentation of a probe (*) appearing in the location of one of the 
pictures. Participants are instructed to indicate the location of the probe by pressing a 
corresponding key on a keyboard as quickly as possible. The position of the food and neutral 
pictures are balanced across trials so that each appears in either location with equal frequency. 
Recordings of the participant’s manual response latency when indicating the location of the 
probe are used to calculate a response latency bias. The logic of this task presumes that 
participants who have an attention bias towards food are quicker in responding to indicate the 
location of the probe when the probe replaces a food stimulus. Thus, the latencies of manual 
responses provide an index for attention bias for food. Positive values indicate faster mean 
latencies (i.e. an attentional bias) to food cues than for neutral cues.  
 Food Challenge Task [16, 39, 63]: The Food Challenge Task will be used to examine cue-induced 
food craving. Participants rate their state levels of food craving using the Food Cravings 
Questionnaire State Version [64, 65] after being presented with filmed cues of highly appetitive 
foods. 
 Taste test: Food intake will be measured by means of a “taste test.” Participants will be 
instructed to rate three bowls of highly palatable food items (chocolate, crisps, fruit gum) in 
terms of their visual attractiveness, smell, and taste. The participants will be told that they are 
free to try as much of the offered items as they like. Consumption will be determined by 
weighing the bowls both before and after the “taste test”.  
 The digit-span forward and backward subtests of the Wechsler Memory Scale III [66] will be used 
to measure working memory capacity. 
 Global eating disorder psychopathology as assessed by the EDE [55, 56].  
 Food Cravings Questionnaire Trait Version [64, 65]: This is a reliable and valid self-report 
questionnaire that measures trait levels of craving for food. 
 Treatment acceptance will be assessed using a feedback form composed of several standard 
questions regarding the acceptance of the intervention [39].  
 
Confidentiality and anonymity of all personal data will be retained throughout the entire study. 
Manual files will be securely locked in a lockable filing cabinet, and all electronic files will be 
password protected. Identifying information will be removed from the data, stored separately and 
replaced with a numeric identification code. The master list of names which correspond to each 
participant's numeric identification code will be stored electronically and will be password 
protected. This information will only be accessible to key researchers involved in the study. 
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Randomisation 
Randomisation will be performed independently from the trial team by a central study office at 
Heidelberg University Hospital using a specific randomisation software (RANDI2). Randomisation will 
be stratified for BN and BED in a 1:1 ratio. Participants in the sham group will be offered the 
opportunity to receive real CBM after the end of follow-up.  
 
Blinding 
Participants and assessors using the EDE will be blinded to treatment allocation throughout, i.e., the 
study will be conducted in a double-blind fashion. To assess whether allocation concealment has 
been successful, participants will be asked to guess the treatment allocation at the end of treatment 
and to indicate how certain they are of this guess. Participants will be debriefed and un-blinded to 
group allocation upon completion of the 2 months follow-up.  
 
Analyses 
To determine quality, completeness, and variability of the outcome measures, descriptive statistical 
analyses and graphical methods will be used. To evaluate treatment-specific changes over time in 
patients, a 2 x 2 repeated measures ANOVA with group as between-subject factor and time as 
within-subject factor will be applied. The size of the treatment effect on the outcome measure (EDE) 
will be the difference in outcome data between those in the two treatment conditions at follow-up. 
Additionally, multiple regression models will permit exploration of the relationship between changes 
in the cognitive measures and symptom improvement. No interim analyses are planned. A two-
tailed significance level of p < .05 will be used throughout. Both completer and intent-to-treat 
analyses will be performed. Missing values will be replaced by using the Last Observation Carried 
Forward (LOCF) method for the intent-to-treat analysis. As this is a pilot trial resources do not 
stretch to setting up a Monitoring Committee. Analyses will be conducted by the principal 
investigators. As CBM is a safe procedure with no known side effects we do not expect any 
unexpected adverse reactions, serious or unexpected serious adverse reactions. We will report any 
adverse reactions and serious adverse events. It is intended that the results of the study will be 
reported and disseminated by the principal investigators at international conferences and in peer-
reviewed scientific journals. 
 
Discussion 
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The ABBA study aims to examine the potential of a novel, computerised short-term treatment 
module for patients with bulimic eating disorders that targets a specific cognitive bias in the 
processing of visual food cues, i.e. automatic approach tendencies towards highly palatable food. 
This is the first study examining this treatment approach in a clinical sample of patients with BN and 
BED. Particularly in view of the high attrition and relapse rates in bulimic eating disorders, novel 
treatment approaches are urgently needed [4, 67]. Strengths of the presented study include a 
rigorous double-blind, randomised controlled design including a strong control condition with a 
similar task and equal dosage, and the assessment of potential action mechanisms. Several potential 
practical and operational issues, however, may pose challenges to the successful and timely 
completion of the study, particularly regarding recruitment and attrition. Patients with EDs are often 
ambivalent about treatment which is reflected in high attrition rates, this may become particularly 
difficult if a participant believes they are receiving sham, or if the treatment and assessments are 
experienced as too burdensome.  
 
Trial status 
Participant recruitment and data collection have already begun by the time of manuscript 
submission.  
 
List of abbreviations 
BN = Bulimia Nervosa; BED = Binge Eating Disorder; CBM = Cognitive Bias Modification; UK = United 
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World Health Organisation; ICMJE = International Committee of Medical Journal Editors; DSM = 
Diagnostic and Statistical Manual of Mental Disorders; AAT = Approach-Avoidance Task; CONSORT = 
Consolidated Standards of Reporting Trials; EDE = Eating Disorder Examination 
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